Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples